Inside Solid Tumor Therapies with BlueSphere Bio’s CEO Dr. David Apelian

<p>BlueSphere Bio&apos;s CEO Dr. David Apelian explains the difficulties associated with treating solid tumor cancers as well as what the CGT sector needs to get right in the short term and why.</p>